Business Leadership

Wheeler Bio Appoints Marc Helouin as Chief Quality and Regulatory Officer

Wheeler Bio

Alternative Excipient

Preparing Today for a Potential Ban on Titanium Dioxide in Pharmaceutical Drug Products

Almut von der Brelie

MilliporeSigma

Quality Culture

Does Your Biologics CDMO Truly Have a Culture of Quality?

Joe Payne

Scorpius BioManufacturing

Pharmaceutical Consultancy

Staying Ahead of the Curve with Outsourced Program Management

PharmaLex

Controlled Substances in Clinical Trials

Controlled Substances in Clinical Trials: Considerations, Challenges, and Growing Demand

Rich Nelson; John Hufnagel; Rachel Castro

PCI Pharma Services

Overcoming the Challenges of an Ever-changing Biopharma Landscape

Integrity

Cloud Regulatory Compliance

Cloud Control: Maintaining Compliance as Regulated Apps Move Off Premise

Thierry Dietrich, Ph.D.

Audit Service Merger

Merger of Rephine with Forum Auditorias & TDV Creates Clear Market Leader in Global GMP Audit Services

Rephine

M&A

ProductLife Group Strengthens Foothold in Northern Europe with Pharma IT Acquisition

ProductLife Group

Bioanalytics

The Bioanalytical Development Journey

Nick Raja, Ph.D.

Scorpius BioManufacturing

CAPA Management

CAPA Management is Worth Doing, and Worth Doing Well

Helen Lowe

Regulatory Compliance

Addressing Regulatory Challenges for Ophthalmic Combination Products

Jeff Tremain; Ania VanDyke

AbbVie Contract Manufacturing

Animal Health

Leveraging Broad Capabilities in the Growing Animal Health Market

TriRx Pharmaceutical Services

Cell Therapies

A Personalized Cell Therapy Chain Management Platform

Matthew Lakelin

TrakCel